Health care: prescription drug costs and pharmacy benefit managers
What they say
Her campaign says it will lower prescription drug costs by holding pharmacy benefit managers accountable.
“Lower prescription drug costs by increasing transparency and holding pharmacy benefit managers accountable.”
In their own words, dated
“Because no family in Iowa should ever have to treat a medical decision like a financial one. And I know there's a lot more to do.”
What the record shows ·
No bill among her 119th Congress sponsorships (33 bills and resolutions) or cosponsorships (237), nor among the 95 she sponsored and 924 she cosponsored across the 117th through 119th Congresses, listed on Congress.gov carries pharmacy benefit managers in its title. She cosponsored H.R. 8339, the Drug Origin Transparency Act of 2026 (April 16, 2026), whose official title describes a drug-manufacturing reporting bill rather than a price-transparency or pharmacy-benefit-manager bill, and H.R. 1492, which would equalize the Medicare negotiation period between small-molecule drugs and biologics (June 6, 2025); both were referred to committee. She sponsored H.R. 3878, the RNs for Rural Health Act of 2025 (June 10, 2025), which matches the rural-health-workforce plank.
Limit: This check covers bill titles in the 117th through 119th Congresses; a pharmacy-benefit-manager provision inside a larger bill would not appear. H.R. 1492 concerns the timing of Medicare price negotiation and is not obviously in either direction of the plank; its text was not read for this card.